As assay technologies continue to improve, biophysical techniques such as X-ray crystallography, nuclear magnetic resonance (NMR), surface plasmon resonance (SPR), and isothermal titration calorimetry (ITC) have become a key component of drug discovery platforms for many pharmaceutical companies and laboratories. Biophysical methods are widely used for hit discovery (fragment-based screening and high-throughput screening), hit validation, in-depth characterization of compound binding, and lead compound optimization.
CD BioSciences is committed to providing researchers with comprehensive, sensitive, and professional biophysical analysis services to advance early characterization of compounds and drug discovery by incorporating relationships between kinetics, molecular structure, and interactions.
CD BioSciences' biophysical analysis service team has rich practical experience and professional knowledge and can provide personalized analysis solutions for different needs of drug development. We are committed to providing customers with efficient, accurate, and reliable biophysical analysis services and promoting innovation and progress in drug R&D.
We offer X-ray crystallography techniques to determine the spatial structure and conformational information between drugs and target molecules, and to reveal the mechanism of their interaction. By exposing protein crystals to X-ray beams and determining X-ray diffraction patterns, the atomic level structure of a protein can be deduced. Currently, our X-ray crystallography analysis service is widely used in structure-based drug design (SBDD) and drug-target molecule interaction studies.
We provide nuclear magnetic resonance (NMR) technology for drug discovery to identify, characterize, and validate active pharmaceutical ingredients for compound structure determination, analysis, and other studies of their content and identification of impurities. Our isothermal titration calorimetry (ITC) technology evaluates the strength and duration of drug-biomolecule interactions to aid in the drug screening and optimization process.
Our service platform provides a variety of spectroscopic analysis techniques such as fluorescence, infrared, and nuclear magnetic resonance spectroscopy for structural, purity, and content determination of drugs to ensure their quality and stability. In addition, mass spectrometry with high sensitivity and resolution provides the basis for precise structural identification of drug molecules and analysis of trace components.
CD BioSciences is a biotechnology company focused on biophysical services. We are proficient in both chemistry and biophysics, and have a comprehensive biophysical platform containing a wide range of advanced technologies.